Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; (TSX: $FAF.TO) (TSXV: $N.V) (TSXV: $KHRN.V) (TSX: $APHA.TO) (NYSE: $APHA)
Delta, Kelowna, BC, January 14, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/01141FAF-N-KHRN-APHA.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s we look at a few early announcements.
But first, Purpose Investments Inc. launched the Medical Cannabis & Wellness UCITS ETF, representing Purpose’s first offering in the European market. The Fund is being made available through Purpose’s partnership with HANetf, an independent European ETF specialist backed by renowned investor Steve Cohen’s Point72 Ventures.
The first of its kind for European investors, the Fund listed earlier today on the Deutsche Boerse XETRA exchange in Germany. It will be listed on the London Stock Exchange in the UK and the Borsa Italiana in Italy later this month.
“The medical cannabis industry was pioneered in Canada, and we’re thrilled with the opportunity to partner with HANetf to take what we have learned from our Purpose Marijuana Opportunities Fund (MJJ) to Europe. We believe that the cannabis sector is still in the infancy stages of a multi-year growth phase and that there is ample opportunity for innovation and new discoveries. We are very excited to embark on this journey with HANetf in a global investor market,” said Som Seif, CEO and founder of Purpose Investments.
The Fund offers European investors unique exposure to the global medical cannabis market and the CBD wellness sector. Additionally, the Fund invests in ancillary services that support companies within the medical cannabis and CBD categories.
“Up until now, European investors have experienced restricted access to the cannabis market. With the launch of this truly innovative ETF, there is now a product for investors who want exposure to the cannabis industry through a pre-screened basket of Cannabis securities and in a regulated UCITS ETF. Due to the operational and legal due diligence that has gone into developing this truly innovative ETF, investors can readily access an investment vehicle which can significantly reduce their legal risk versus investing directly in single cannabis securities. It is also is a great way to diversify as investors don’t need to research each individual security and the ETF may help to withstand the short-term volatility of individual securities, potentially making for a lower risk, longer-term investment,” said Hector McNeil, co-Founder and co-CEO of HANetf.
For more information on the Fund, please visit: https://www.hanetf.com/product/6/fund/the-medical-cannabis-and-wellness-ucits-etf-acc
Fire & Flower Holdings Corp. (TSX: FAF) and its wholly-owned subsidiary Fire & Flower Inc., announced that it has achieved the milestone of 45 open and operating cannabis retail stores.
Fire & Flower has previously stated that the Company anticipated achieving the milestone of 45 retail cannabis stores by the end of its fiscal year, being February 1, 2020. The Company has achieved this milestone several weeks in advance of its previously stated goal and today has 46 open and operating stores across its retail network.
The new stores included in the Company's milestone achievement are located at the following addresses:
● 1108 4th street SW, Calgary, Alberta
● 6004 Country Hills Blvd NE, Calgary, Alberta
● 212, 11245 Valley Ridge Drive NW, Calgary, Alberta
● 350, 590 Baseline Road, Sherwood Park, Alberta
● 19-99 Wye Road, Sherwood Park, Alberta
● 1276 3 Avenue South, Lethbridge, Alberta
● 10 Westwind Drive, Spruce Grove, Alberta
● 40 Hewlett Park Landing, Sylvan Lake, Alberta
● 4331-52 Avenue, Whitecourt, Alberta
"Fire & Flower is committed to delivering on the targets that we have provided to our shareholders and reaching 45 cannabis retail stores several weeks in advance of when we had anticipated to reach this target is a clear demonstration of our discipline in achieving our goals," shared Trevor Fencott, Fire & Flower's Chief Executive Officer. "Achieving this aggressive goal is a testament to our deep retail experience and strong management team. As the cannabis industry continues to face headwinds, Fire & Flower is well positioned to continue to achieve growth and demonstrate leadership in the category."
The Company continues to focus on opening new retail stores across Alberta, where the AGLC continues to issue retail licences, and in the province of Ontario where open licensing has commenced. Fire & Flower is also closely monitoring regulatory environments and taking proactive steps in provinces across Canada to ensure early market entry when private retail opportunities emerge.
Namaste Technologies Inc. (TSXV: N) (OTC: NXTTF), a leading online platform for cannabis products, accessories, and responsible education today announced that Choklat Inc., an Alberta-based craft chocolate manufacturer and chocolatier in which Namaste holds a 49% equity position, has received a processing license from Health Canada to produce a line of chocolate bars, drink mixes and infused sugar.
"Receiving the processing license from Health Canada is a significant achievement and milestone," said Brad Churchill, CEO of Choklat. "We look forward to introducing our cannabis infused product line, products with a pure chocolatey taste with no aftertaste, across Canada leveraging the extensive B2B sales channels that CannMart Inc. has built. Our high-quality cannabis infused bars and beverages will be based on our own chocolate recipe made from a special cocoa bean sourced from the jungles of South America. This is an exciting time for Choklat, CannMart and Namaste as we enter the competitive cannabis 2.0 landscape."
"Brad Churchill is a true pioneer when it comes to the actual production of chocolate, and he is now applying his extensive experience and passion to produce high quality cannabis-infused chocolates," said Meni Morim, Chief Executive Officer at Namaste Technologies Inc. "We believe there is pent up demand for cannabis-infused edible products on a national scale. Choklat is one of the first food processors in Canada to receive its processing license from Health Canada and we expect their products to be on shelves in March, allowing for the Health Canada notice period. We invested in Choklat not only to maximize the significant market opportunity for cannabis-infused edibles but also because we see Brad as a true craftsman in his trade and the quality of his products speak for themselves."
The Cannabis Regulations require licenced processors to submit a notification to Health Canada of their intent to sell each novel cannabis product in Canada at least 60 calendar days before making such cannabis products available for sale. CannMart will be submitting up to 11 unique product SKUs to Health Canada for the new derivative product formats that the Company intends to offer for sale beginning in March. New products are expected to include dark, white and milk chocolate bars, chocolate-based beverages and infused sugar, that have been formulated, developed and packaged to meet the regulatory requirements set out by Health Canada. These new product formats will be added to Namaste's e-commerce website CannMart.com and offered through provincial cannabis stores in authorized markets.
What sets Choklat apart from other chocolatiers is that Choklat imports premium cocoa beans in the world, then roasts, grinds and refines them on-site into chocolate that meets exacting taste specifications. Creating the chocolate allows for complete control over the quality and taste of the final products which Namaste and Choklat believe provides an advantage over competitors. Namaste, CannMart and Choklat are all about treating customers with respect and integrity and using only the highest quality products and natural ingredients.
Choklat has existing sales of non-infused products through both its online e-commerce site and a network of distributors across Canada. The chocolate manufacturer has experienced significant expansion while preparing for the legalization of edibles and has non-infused products available in over 150 retail outlets across Canada, including an increasing number of Safeway and Sobeys stores in Western Canada. Choklat has also applied for and received its FDA number for the sale of non-infused chocolate bars in the United States.
Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF), a vertically integrated cannabis leader with core operations in Latin America,announced the opening of Zerenia, a fully integrated medical care clinic designed to meet patient health and well-being. Operating in a 15,000 sq. ft facility in Bogota's prime medical services district, the clinic increases Khiron's clinical capacity by 75% and forms part of the Company's patient acquisition strategy as it prepares for the issue of cannabis prescription in Colombia.
Zerenia offers a person-centered integrated care model, with the concept of integrative medicine combining traditional and complementary medicine, and with evidence-based treatments and high professional practices. Services are delivered across multiple clinical units include: Pain management, mental health, surgical, neurology and dentistry, supported by rehabilitation, complementary medicine and diagnostic technology, involving programs for managing multiple symptoms in different pathologies. Prominently located in Bogota's city centre, Zerenia builds on the integration and growth of the Company's wholly-owned Ilans neurological clinics and its over 60 physicians, and is staffed by a team of health professionals and clinical leaders representing different specialties.
Phase one of the 15,000 sq. ft clinic is open for treatments and phase two will be ready to receive patients in March 2020.
"We are excited to be opening Zerenia in Bogota, a busy city of more than 10 million people and a population increasingly demanding convenient, one-stop access to medical care of the highest professional standards. In a state of the art clinic, our physicians and health care professionals will consult with patients and offer appropriate treatment therapies." Comments Martha Edith Oyuela, Khiron Health Vice President. "For the first time patients will have access to an array of integrated professional, patient-centred options."
"Our strategy in launching Zerenia is to meet a very clear market need to treat the whole patient in one professional environment. With the success of our Ilans clinics, and the growing movement towards integrated medical care, we are leading the market in bringing this concept to Colombia. This strategy further expands our reach to bring patients into the Khiron network, including those that are well suited for cannabis therapies." Adds Khiron CEO and Director Alvaro Torres.
Aphria Inc. (TSX: APHA) (NYSE: APHA) reported its results for the second quarter ended November 30, 2019. All amounts are expressed in thousands of Canadian dollars, unless otherwise noted and except for per gram, kilogram, kilogram equivalents, and per share amounts. The Company also announced that Irwin D. Simon, will officially remove "interim" from his title, effective today. In addition to his responsibilities as Aphria's Chairman of the Board, Mr. Simon had been serving as Interim Chief Executive Officer since February 2019.
"We are very pleased with our strong growth and execution in Canada demonstrated by our increase in adult-use cannabis revenue and positive adjusted EBITDA as a result of our compelling brands and market positioning," stated Irwin D. Simon, Chairman and Chief Executive Officer. "We are continuing to expand our capabilities internationally with solid progress during the quarter in Germany and South America and look to monetize non-core assets. We are confident in our market position and our ability to generate sustainable profit growth. I am honoured to continue to work closely with our tremendous team around the world to fuel growth and value for all of our stakeholders. Going forward, we believe our brands, cultivation expertise, cash position and balance sheet will continue to differentiate us in the cannabis industry, and we remain focused on the highest return opportunities for growth."
Some of the key Operating Highlights included, a revenue for adult-use cannabis of $29.0 million in the second quarter, an increase of 46% from prior quarter, a net cannabis revenue of $33.7 million in the second quarter, an increase of 9% from prior quarter and a net revenue of $120.6 million in the second quarter, an increase of 457% from prior year quarter and decrease of 4% from prior quarter.
Aphria was also recognized for seven awards at the 6th Annual Canadian Cannabis Awards with all five of Aphria's medical and recreational brands receiving awards, as well as Broken Coast's Master Grower, Kevin Anderson, winning 'Master Grower' accolades and Aphria's Solei's CBN Renew oil 'Innovation of the Year'.
Carl Merton, Aphria's Chief Financial Officer commented, "We are updating our annual outlook with a little over four months left in our fiscal year to reflect certain market dynamics that have evolved relative to our initial expectations. We look forward to generating an acceleration in our revenue and profit growth in the second half of the fiscal year and continue to believe the Canadian and international cannabis industry outlook remains robust. Aphria is well positioned for long-term sustainable growth as we continue to manage the controllable aspects of our business."
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Cannabis Social Media
Contact Investorideas.com
800-665-0411
